再生医学市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100001194
  • Category : Biotechnology
  • No. of Pages : 201
Buy Now

Regenerative Medicine Market Opportunities 2031

Buy Now

2021年再生医学市场价值为117.7亿美元,预计将达到美国到 2031 年将达到 374.8 亿美元;预计 2022 年至 2031 年复合年增长率为 17.9%。

再生医学是一个创新的医学领域,它开发替代/再生人体细胞、组织或器官以恢复正常功能的方法。它可以通过刺激人体自身的修复机制来治愈组织或器官。再生医学允许科学家在实验室中培育组织和器官,并在无法自行愈合时将其安全地植入体内。

越来越多地采用基因疗法、干细胞疗法和组织工程;细胞和基因疗法的批准数量不断增加;再生医学领域的技术进步是推动市场增长的关键因素。然而,这些疗法的高昂成本阻碍了市场扩张。

再生医学市场根据类型进行分析,应用和地理。该报告对再生医学市场进行了深入的洞察和分析,强调了市场趋势、技术进步和市场动态等各种参数,以及领先市场参与者的竞争格局分析。

战略见解

再生医学市场利润丰厚的区域

Regenerative Medicine Market

< h3>市场洞察

细胞和基因治疗批准数量的增加促进了再生医学市场的增长

细胞和基因疗法数量的增加可能会推动市场增长。例如,2022 年 5 月,美国食品和药物管理局 (FDA) 批准诺华 Kymriah CAR-T 细胞疗法用于治疗复发或难治性 (r/r) 滤泡性淋巴瘤 (FL) 成年患者。 Kymriah 是第一个获得批准的 CAR-T 细胞疗法,由诺华和宾夕法尼亚大学佩雷尔曼医学院共同开发。 2022 年 2 月,杨森生物技术公司的 CARVYKTI(ciltacabtagene autoleucel;cilta-cel)获得美国 FDA 批准,用于治疗成人复发性或难治性多发性骨髓瘤。

  • 2022 年 8 月,Bluebird Bio, Inc. 的 Zynteglo (betibeglogene autotemcel) 获得美国 FDA 批准,这是第一个基于细胞的基因疗法用于治疗需要定期输注红细胞的β地中海贫血成人和儿童患者。
  • 2021 年 3 月,美国 FDA 批准 Celgene公司的 Abecma (idecabtagene vicleucel) 是一种基于细胞的基因疗法,用于治疗对治疗没有反应或即使在不同类型的治疗后疾病仍复发的多发性骨髓瘤成年患者。
< h3>基于类型的见解

根据类型,再生医学市场分为细胞免疫疗法和细胞治疗产品、组织工程产品和基因治疗产品。细胞疗法免疫疗法和细胞治疗产品细分市场在 2021 年占据最大的市场份额,预计将在 2021 年实现最高的复合年增长率预测期。

再生医学市场,按类型划分 – 2021 年和 2031 年

 

Regenerative Medicine Market

基于应用程序的见解

根据应用,再生医学市场分为肌肉骨骼疾病、伤口护理、肿瘤学、眼部疾病和糖尿病。肿瘤学领域在 2021 年占据最大的市场份额,预计将占据最高的市场份额2022 年至 2031 年复合年增长率。

由于为 COVID-19 患者开发新疗法的紧迫性,COVID-19 大流行为市场参与者创造了增长机会。细胞和基因治疗研究行业启动了多个研究项目。例如2021 年 11 月,Longeveron Inc. 启动了 1 期试验,以测试 Longeveron 间充质干细胞 (LMSC) 在患有因 COVID-19 导致的轻度至重度急性呼吸窘迫综合征 (ARDS) 的成人中的安全性。< /p>

2022年,北美占据再生医学市场最大份额。市场增长归因于再生医学领域研发活动的不断增加。亚太地区预计增长最快预测期内的复合年增长率。中国、日本和印度是该地区再生医学市场的主要贡献者。干细胞研究的不断增加、政府对细胞和基因研究的支持不断增加以及生物技术基础设施的改善是推动该地区再生医学市场增长的因素。亚太地区的市场增长。

按地理位置,再生医学市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区),亚太地区(中国、日本、印度、韩国、澳大利亚以及亚太地区其他地区)、中东和非洲(阿联酋、沙特阿拉伯、非洲以及中东和非洲其他地区)以及南部地区和中美洲(巴西、阿根廷以及南美洲和中美洲的其他地区)。

公司简介

  • Integra LifeSciences
  • 吉利德科学公司
  • 诺华公司
  • Vericel Corporation
  • 莱特医疗集团 NV
  • MiMedx 集团
  • Osiris Therapeutics, Inc.
  • Stryker Corporation
  • Spark Therapeutics, Inc.
  • 美敦力公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Integra LifeSciences Corporation
2. Gilead Sciences
3. Novartis
4. Vericel Corporation
5. Wright Medical
6. MiMedx
7. Osiris Therapeutics
8. Stryker Corporation
9. Spark Therapeutics
10. Medtronic
11. 3M
12. Allergan Plc
13. Aspect Biosystems
14. Bluebird Bio
15. Amgen, Inc.
16. Smith and Nephew Plc
17. Corestem, Inc.
18. Organogenesis
19. Kite Pharma
20. Spark Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..